Servier, committed to helping those who fight against the Covid-19
All the news from Servier Group
COVID-19: Servier China on the digital innovation front
Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline
World Autism Awareness Day: Servier is committed
Oncology: a first Marketing Authorization under its own name for Servier in Japan
Covid-19: Servier part of the Health Innovation Coalition in France
COVID-19: Beware of non-approved drugs and fake remedies!
Coronavirus Information (COVID-19)
Cardiology: Servier awards its research fellowship to a young European researcher